Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease.
Messina D, Annesi G, Serra P, Nicoletti G, Pasqua A, Annesi F, Tomaino C, Cirò-Candiano IC, Carrideo S, Caracciolo M, Spadafora P, Zappia M, Savettieri G, Quattrone A. Messina D, et al. Among authors: spadafora p. Neurology. 2002 Mar 12;58(5):828-9. doi: 10.1212/wnl.58.5.828. Neurology. 2002. PMID: 11889255 No abstract available.
CAV3 T78M mutation as polymorphic variant in South Italy.
Spadafora P, Liguori M, Andreoli V, Quattrone A, Gambardella A. Spadafora P, et al. Neuromuscul Disord. 2012 Jul;22(7):669-70; author reply 670-1. doi: 10.1016/j.nmd.2012.03.007. Epub 2012 May 16. Neuromuscul Disord. 2012. PMID: 22595201 No abstract available.
The role of VLA4 polymorphisms in multiple sclerosis: an association study.
Andreoli V, Cittadella R, Valentino P, Condino F, La Russa A, Liguori M, Manna I, Spadafora P, Nisticò R, Pirritano D, Clodomiro A, Quattrone A. Andreoli V, et al. Among authors: spadafora p. J Neuroimmunol. 2007 Sep;189(1-2):125-8. doi: 10.1016/j.jneuroim.2007.06.015. Epub 2007 Jul 3. J Neuroimmunol. 2007. PMID: 17609118
Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study.
Zappia M, Annesi G, Nicoletti G, Arabia G, Annesi F, Messina D, Pugliese P, Spadafora P, Tarantino P, Carrideo S, Civitelli D, De Marco EV, Cirò-Candiano IC, Gambardella A, Quattrone A. Zappia M, et al. Among authors: spadafora p. Arch Neurol. 2005 Apr;62(4):601-5. doi: 10.1001/archneur.62.4.601. Arch Neurol. 2005. PMID: 15824260 Clinical Trial.
62 results